Le Lézard
Classified in: Business
Subject: STH

IIROC Trading Halt - TRZ


TORONTO, June 27, 2019 /CNW/ - The following issues have been halted by IIROC:

Company: Transat A.T. Inc.

TSX Symbol: TRZ (All Issues)

Reason: Pending News

Halt Time (ET): 8:01 AM

IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

SOURCE Investment Industry Regulatory Organization of Canada (IIROC) - Halts/Resumptions


These press releases may also interest you

at 02:57
For Q1 2024, NORDEN reports a profit of USD 62 million (approx. DKK 435 million). Free cash flow in the first quarter amounted to USD -50 million (approx. DKK -350 million). Return on invested capital (ROIC) was 26% by end of Q1 based on the last...

at 02:45
ASE Technology Holding Co., Ltd. (TWSE: 3711, NYSE: ASX) ("We", "ASEH", or the "Company"), the leading provider of semiconductor assembly and testing services ("ATM") and the provider of electronic manufacturing services ("EMS"), today reported its...

at 02:39
MYTILINEOS Energy & Metals (RIC: MYTr.AT) (Bloomberg: MYTIL.GA) announces its Q1 2024 financial results. 10% increase in Net Profit after minorities to ?158 million vs. ?143 million in Q1 2023. Earnings per Share came in at ?1.141, an increase of...

at 02:30
Allied Market Research published a report, titled, "Pension Administration Software Market by Component (Solution and Services), Deployment Mode (On-Premise and Cloud), Type (Public Pension and Private Pension), End User (Employers, Pension Plan...

at 02:26
Having consistently outperformed its targets and strategic goals, MYTILINEOS Energy & Metals ("MYTILINEOS") has initiated a review and evaluation of its strategic options, in consultation with its financial, legal and tax...

at 02:22
Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the first quarter 2024 First Quarter 2024 Total revenue increased 19 per cent, 20 per cent at constant exchange rates, (CER)1, to SEK 6,256 M (5,239)Haematology revenue...



News published on and distributed by: